During Phase 2 of PPI's ramp-up plan, experimental work is being carried out through collaborations with external laboratories specializing in various technology components. These include (see recent papers):

SISCAPA method for peptide quantitation in digests:

University of Victoria, British Columbia, Canada

Cell Signaling Technology

Applied Biosystems

Non-redundant multisource plasma proteome:

Inpharmatica Ltd., London, United Kingdom

Biological Sciences Department, Pacific Northwest National Laboratory, Richland, Washington

Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick Inc., National Cancer Institute at Frederick, Frederick, MD

Large Scale Biology Corporation, Proteomics Division, 20451 Seneca Meadows Pkwy, Germantown, MD